McMahon Anne, Jackson Shelley N, Woods Amina S, Kedzierski Wojciech
Department of Ophthalmology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.
FEBS Lett. 2007 Nov 27;581(28):5459-63. doi: 10.1016/j.febslet.2007.10.050. Epub 2007 Nov 5.
Stargardt disease-3 (STGD3) is a juvenile dominant macular degeneration caused by mutations in elongase of very long chain fatty acid-4. All identified mutations produce a truncated protein which lacks a motif for protein retention in endoplasmic reticulum, the site of fatty acid synthesis. In these studies of Stgd3-knockin mice carrying a human pathogenic mutation, we examined two potential pathogenic mechanisms: truncated protein-induced cellular stress and lipid product deficiency. Analysis of mutant retinas detected no cellular stress but demonstrated selective deficiency of C32-C36 acyl phosphatidylcholines. We conclude that this deficit leads to the human STGD3 pathology.
斯特格黄斑营养不良3型(STGD3)是一种由超长链脂肪酸延长酶4突变引起的青少年显性黄斑变性。所有已鉴定的突变都会产生一种截短蛋白,该蛋白缺乏在内质网(脂肪酸合成位点)中保留蛋白质的基序。在这些对携带人类致病突变的Stgd3基因敲入小鼠的研究中,我们研究了两种潜在的致病机制:截短蛋白诱导的细胞应激和脂质产物缺乏。对突变视网膜的分析未检测到细胞应激,但显示C32 - C36酰基磷脂酰胆碱存在选择性缺乏。我们得出结论,这种缺乏导致了人类STGD3的病理变化。